S. Richard Turner

Materials ScienceChemistry

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 5 papers. Top paper: “US National Institutes of Health Prioritization of SARS-CoV-2 Variants”.

US National Institutes of Health Prioritization of SARS-CoV-2 Variants

Emerging infectious diseases(2023)10.3201/eid2905.221646

N/A

0.208DataRank · unranked

3 citations

Arghavan Alisoltani, Debbie Bratt, Liel Cohen-Lavi, Bethany L. Dearlove, Christian Drosten +29 more

The impact of S2 mutations on Omicron SARS-CoV-2 cell surface expression and fusogenicity

Emerging Microbes & Infections(2023)10.1080/22221751.2023.2297553

N/A

0DataRank · unranked

16 citations

Manon Laporte, S. Richard Turner, Umut Karakus, Ana S. Gonzalez‐Reiche, Adriana van de Guchte +7 more

Global variation in prior exposure shapes antibody neutralization profiles of SARS-CoV-2 variants up to BA.2.86

bioRxiv (Cold Spring Harbor Laboratory)(2024)10.1101/2024.03.27.586820

N/A

0DataRank · unranked

0 citations

Gayatri Amirthalingam, Dalan Bailey, Dan H. Barouch, Kevin R. Bewley, Kevin Brown +27 more

Near real-time data on the human neutralizing antibody landscape to influenza virus to inform vaccine-strain selection in September 2025

Virus Evolution(2025)10.1093/ve/veaf086

N/A

0DataRank · unranked

5 citations

John Huddleston, Andrea N. Loes, S. Richard Turner, Jover Lee, Ian Barr +15 more

SARS-CoV-2 infection imprints neutralising antibody responses in the absence of vaccination

Research Square(2025)10.21203/rs.3.rs-6347062/v1

N/A

0DataRank · unranked

3 citations

Adam Abdullahi, Rebecca Morse, Mark T. K. Cheng, Fehintola Ige, Martin Edun +26 more